Fortress Biotech Inc. (NASDAQ:FBIO)’s share price traded up 3.2% during trading on Wednesday . The company traded as high as $2.91 and last traded at $2.86, with a volume of 68,490 shares. The stock had previously closed at $2.77.

Separately, FBR & Co reiterated an “outperform” rating on shares of Fortress Biotech in a report on Wednesday, July 20th.

The company has a 50-day moving average price of $2.89 and a 200 day moving average price of $3.00. The stock’s market cap is $139.19 million.

Fortress Biotech (NASDAQ:FBIO) last released its quarterly earnings results on Tuesday, August 9th. The biopharmaceutical company reported ($0.31) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.29) by $0.02. Equities research analysts expect that Fortress Biotech Inc. will post ($1.03) earnings per share for the current fiscal year.

Fortress Biotech, Inc, formerly Coronado Biosciences, Inc, is a biopharmaceutical company. The Company is involved in the development of immunotherapy agents for the treatment of autoimmune diseases and cancer. Its sole product candidate is CNDO-109. The Company is also focused on acquiring, developing and commercializing pharmaceutical and biotechnology products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.